Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Abeona Therapeutics (ABEO) will participate in three investor conferences in September 2026, featuring fireside chats, a company presentation, and investor meetings.

Rhea-AI Summary

Abeona Therapeutics (ABEO) will participate in three investor conferences in September 2026, featuring fireside chats, a company presentation, and investor meetings.

Events include the Cantor Global Healthcare Conference on September 9, the H.C. Wainwright Global Investment Conference on September 15, and the Morgan Stanley Global Healthcare Conference on September 16, with live webcasts and limited-time replays via Abeona's investor website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2026:

• Cantor Global Healthcare Conference 2026: Fireside chat on Wednesday, September 9, 2026, at 8:00 a.m. ET and investor meetings.
  
  
• H.C. Wainwright 28th Annual Global Investment Conference: Company presentation on Tuesday, September 15, 2026, at 12:00 p.m. ET and investor meetings.
  
  
• Morgan Stanley 24th Annual Global Healthcare Conference: Fireside chat on Wednesday, September 16, 2026, at 11:30 a.m. ET and investor meetings.
  
  

Live webcasts of the fireside chats and company presentation can be accessed on the Investors section of the Abeona website under “Events” at https://investors.abeonatherapeutics.com/events, where replays of available events will also be accessible for a limited time.

About Abeona Therapeutics
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN^® (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio, serves as the manufacturing site for ZEVASKYN commercial production. The Company’s development portfolio features ABO-701 (PSMA-SIR-T™), a potentially first-in-class engineered T-cell therapy targeting PSMA, engineered to overcome the core failures of cell therapies in solid tumors. For more information, visit www.abeonatherapeutics.com.

ZEVASKYN^®, Abeona Assist^®, Abeona Therapeutics^®, and their related logos are trademarks of Abeona Therapeutics Inc.

Contacts:

Investor and Media:
Greg Gin
VP, Investor Relations and Corporate Communications
Abeona Therapeutics
ir@abeonatherapeutics.com

Investor:
Lee M. Stern
Meru Advisors
lstern@meruadvisors.com

FAQ

What investor conferences will Abeona Therapeutics (ABEO) attend in September 2026?

Abeona Therapeutics will attend three conferences in September 2026: the Cantor Global Healthcare Conference, the H.C. Wainwright 28th Annual Global Investment Conference, and the Morgan Stanley 24th Annual Global Healthcare Conference, with fireside chats, a company presentation, and investor meetings.

When is Abeona Therapeutics' fireside chat at the Cantor Global Healthcare Conference 2026?

Abeona Therapeutics' fireside chat at the Cantor Global Healthcare Conference 2026 is scheduled for Wednesday, September 9, 2026, at 8:00 a.m. ET, followed by investor meetings.

When is Abeona Therapeutics' presentation at the H.C. Wainwright Global Investment Conference 2026?

Abeona Therapeutics' company presentation at the H.C. Wainwright 28th Annual Global Investment Conference is on Tuesday, September 15, 2026, at 12:00 p.m. ET, along with investor meetings.

When is Abeona Therapeutics' fireside chat at the Morgan Stanley Global Healthcare Conference 2026?

Abeona Therapeutics' fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference is on Wednesday, September 16, 2026, at 11:30 a.m. ET, with additional investor meetings.

How can investors access the Abeona Therapeutics (ABEO) webcasts for the September 2026 conferences?

Live webcasts of Abeona Therapeutics' fireside chats and company presentation can be accessed via the Investors section of its website under “Events” at https://investors.abeonatherapeutics.com/events, where replays of available events will also be accessible for a limited time.